Amanda Irwin and Alan Iglesias
The 5-Minute Ticker – One stock, two friends, five minutes
The 5-Minute Ticker is your quick daily dive into the stock market. Each episode, Amanda Irwin and Alan Iglesias — two AI friends here to keep you company — break down one ticker in about five minutes: what the company does, why it matters, and the key numbers you should know. No jargon, no fluff, just clear insights you can listen to on your coffee break. This podcast is for informational purposes only. Information may not be complete or accurate. It does not constitute financial, investment, legal, or other professional advice.
Author
Amanda Irwin and Alan Iglesias
Category
Podcast website
Latest episode
Jul 10, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
NVTS Stock: 45% Revenue Drop - Too Risky Now? 12.05.2026 5:40
Navitas Semiconductor ($NVTS) began as a GaN pioneer, packing high-efficiency power ICs into tiny fast chargers and shipping millions of units. Their bold "Navitas 2.0" pivot away from low-margin mobile toward AI data centers, EVs, and solar has crushed near-term sales as they trade immediate revenue for a shot at much bigger markets. They still have attractive unit economics, design wins, and a h...
RKLB Stock: $602M 2025 Revenue - Buy the Dip? 11.05.2026 6:00
Rocket Lab ($RKLB) has grown from a scrappy small-launch provider into a vertically integrated space company building rockets, satellites, and key spacecraft components. They've broadened beyond Electron launches into higher-margin Space Systems work and have been winning big government deals that suggest a strong pipeline. The catch is they remain unprofitable and are sinking massive resource...
APP Stock: 70% Revenue Surge to $5.48B - Buy, Sell, or Hold? 10.05.2026 5:35
AppLovin ($APP) morphed from a stealth app-discovery tool into an AI-driven ad-tech powerhouse through bold acquisitions and a publishing arm. Its AXON engine and MAX platform knit developers and advertisers together, converting ad spend into unusually high-margin, cash-generating software revenue. Management is pushing AXON 2.0 and eyeing e-commerce and connected TV as the next big growth stages,...
PANW Stock: 22% Re-acceleration — Is It Worth It? 09.05.2026 5:17
Palo Alto Networks has become a dominant force by turning a smarter firewall into a full-blown security platform that aims to replace dozens of niche vendors. The company ($PANW) is buying growth and bundling services into integrated suites, which promises stickier revenue but also brings dilution and tricky integrations. That strategy creates tension: a market leader with clear scale and AI-drive...
QCOM Stock: $5.7B Tax Hit, 14% Revenue Rise - Crash Coming? 08.05.2026 5:49
QUALCOMM ($QCOM) built much of the mobile world, pairing Snapdragon chip design with a lucrative licensing business that feels like a golden goose. Recent results showed top-line momentum but a headline one-time tax charge that made profits look far worse than the underlying performance. The company now walks a tightrope: handset cyclical weakness and rivals or customers going in-house threaten th...
VECO Stock: 35% Backlog Gain - Buy or Avoid? 07.05.2026 5:36
Veeco Instruments ($VECO) has quietly remade itself from a mid-century hardware concern into a specialized maker of the precision tools that power AI and high-performance chips. After strategic pivots and a new CEO focus, its semiconductor equipment now drives the bulk of sales and a growing backlog that underpins ambitious guidance for a near-term rebound. A pending merger with Axcelis would crea...
CELC Stock: $2.5B Peak Sales if Approved — Buy or Avoid? 06.05.2026 5:17
Celcuity ($CELC) has built a high-stakes biotech story around a targeted breast cancer drug and a predictive diagnostic platform meant to find the patients most likely to benefit. Their lead candidate, gedatolisib, delivered positive Phase 3 results and earned an FDA Priority Review, with a PDUFA decision set for July 17, 2026 — a true make-or-break moment. The company is pre-revenue and essential...
GBTG Stock: $6.3B Offer - Hold or Fold? 05.05.2026 5:54
Global Business Travel Group has gone from an American Express spin-off to the dominant platform for corporate travel, bulking up through a SPAC and a string of acquisitions that peaked with CWT. Now ($GBTG) sits at a dramatic turning point after a private equity firm surfaced with an all-cash bid to take the company private, turning a public comeback into a tense shareholder choice. Management po...
TEAM Stock: 20% Growth Amid Cloud Shift - Undervalued or Overhyped? 04.05.2026 6:08
Atlassian grew from a $10,000, credit-card startup into a backbone for software teams, and now its future hinges on a bold cloud-first push. The company ($TEAM) is forcing migrations, nudging up prices, and doubling down on AI to weave Jira, Confluence, Trello, and more into a single "System of Work." That strategy has delivered strong momentum and bigger enterprise deals, but persistent GAAP loss...
PI Stock: $10.8M Loss, Q2 Guide $103M - Bargain or Trap? 03.05.2026 5:51
Impinj has been an RFID pioneer, turning tiny chips into a platform that links everyday items to the internet. ($PI) The story blends tech optimism—an integrated razor-and-blades model of endpoint ICs, readers, and software—with semiconductor drama after a recent swing from profit to loss that has investors on edge. A blowout Q2 revenue guide and record early‑2026 bookings hint inventory issues ma...
GTX Stock: $3.75B Sales Midpt Raised - Time to Sell? 02.05.2026 7:09
Garrett Motion has been a hidden champion in turbochargers for 70 years, and as ($GTX) it's trying to turn that legacy into a future-facing play. After steady revenue trends the company even raised its 2026 guidance, a modest vote of confidence that management is navigating a tricky auto cycle. The real bet is on electrification — from electric boosting for hybrids to a major e-powertrain win for...
GKOS Stock: 32% Revenue Jump in 2025 - Hold or Fold? 01.05.2026 5:55
Glaukos has quietly built an empire in micro‑invasive glaucoma surgery, pioneering tiny implants and earning strong surgeon loyalty through years of innovation. The company ($GKOS) has pushed into drug delivery with iDose TR and into corneal therapy with Epioxa, sparking a major revenue surge and forcing management to pour money into launches and marketing. That strategy has produced exciting grow...
COCO Stock: 18% Revenue Jump - Still a Buy? 30.04.2026 6:15
Vita Coco's rise from a NYC van to the brand that put coconut water on the map reads like a classic consumer success story. Vita Coco ($COCO) is still riding health-and-wellness momentum — sales jumped about 18% last year — and the company is stretching into private-label deals and new product lines like PWR LIFT. But there’s real tension: margins slipped, the business depends on a single trop...
MXL Stock: 30% Revenue Rebound - Buy the Dip? 29.04.2026 5:20
MaxLinear ($MXL) designs the high-performance mixed-signal chips that power routers, 5G towers and data centers, and after a brutal industry downturn it's trying to stage a comeback. Revenue bounced roughly 30% in 2025 and management calls the year a “clear inflection point,” signaling renewed demand for its optical and data-center products. Margins are improving, but heavy operating costs and a s...
UEC Stock: $66.8M Revenue Spike - Buy or Avoid? 28.04.2026 5:41
Uranium Energy Corp ($UEC) has quietly evolved from a decades-long hoarder of cheap uranium into a company trying to become America’s low-cost supplier. Their hub-and-spoke ISR footprint and newly permitted processing hubs give the transition real credibility, but lower ore grades mean profitability still depends on sustained high uranium prices. Management has monetized parts of its inventory for...
SXT Stock: 3.5% Revenue Rise - Buy? 27.04.2026 6:14
Sensient Technologies ($SXT) has been quietly coloring and flavoring our world for well over a century, evolving from a distillery into a specialist in sensory ingredients. It supplies colors, flavors, and specialty ingredients to major consumer brands and has doubled down on natural colors as its defining growth bet. After a strong start to the year it raised guidance, suggesting execution is imp...
POET Stock: $430M Cash Piles Up - Buy or Avoid? 26.04.2026 5:23
POET has rebranded itself around photonics and an "Optical Interposer" that promises to move light, not electrons, through AI data centers, and the company says it's finally shifting from years of R&D to commercial production ($POET). They report initial production orders and a clear ramp plan, and they’ve fortified the balance sheet with fresh financing to give the team time to scale. Still,...
AMSC Stock (American Superconductor): $113M Benefit - Buy or Avoid? 25.04.2026 6:12
American Superconductor ($AMSC) has quietly reinvented itself from decades of superconductor R&D into a niche player selling grid orchestration and wind-turbine control systems. The company has finally shown sustained profits, but one-time tax benefits helped inflate a headline quarterly gain, reminding investors to look past the shiny number. With an expanding backlog, a recent Latin America...
PENN Stock (PENN Entertainment): $845M Loss - Turnaround or Trap? 24.04.2026 5:46
PENN Entertainment ($PENN) has been reinventing itself from a regional casino operator into a two‑pronged company that pairs reliable brick‑and‑mortar cash flow with an ambitious online push. After a costly split with Barstool and a painful impairment tied to that pivot, management is banking on an ESPN Bet partnership to finally break into the big leagues. The plan leans on a huge loyalty base an...
URI Stock (United Rentals): $16.1B Revenue Boost - Buy or Avoid? 23.04.2026 5:35
United Rentals ($URI) has grown into a national powerhouse by rolling up hundreds of mom-and-pops into a 1,600+ location network, turning blue-and-white machines into a ubiquitous construction presence. Its two-pronged model—everyday general rentals plus higher-margin specialty gear like trench safety and power solutions—gives it scale and a valuable moat. The company just closed a record revenue...
CAR Stock (Avis Budget): $995M Loss Narrows From $1.82B — Turnaround or Trap? 22.04.2026 5:30
Avis Budget Group has been the airport staple for generations, growing through Budget and Zipcar into a global mobility provider. Its capital-heavy fleet model leaves it vulnerable to swings in used-car values, and a recent half‑billion-dollar EV impairment forced tough strategic decisions. New leadership is tightening fleet discipline, striking partnerships in autonomous mobility, and pushing for...
SMR Stock (NuScale Power): $1.3B Cash Stands Tall Against Long Wait — Buy or Avoid? 21.04.2026 5:45
NuScale Power ($SMR) is pitching a future where compact nuclear reactors can be built in factories and shipped to sites, and its NRC certification gives it a rare first-mover claim in the U.S. But the company is stuck in a slow, expensive pre-commercial stretch—relying on licensing and engineering fees today while the payoff from full-scale manufacturing and deployment may be years away. It has st...
AAL Stock (American Airlines): $54.6B Revenue Record but Profit Collapses — Buy or Avoid? 20.04.2026 4:57
American Airlines ($AAL) reads like a classic American comeback story — a pioneer turned industry behemoth born from crisis and a transformative merger. Its vast hub-and-spoke network and lucrative AAdvantage program give it scale and bright spots beyond just ticket sales. Still, a stumble in profitability and a mountain of debt leave a lot of performance hinging on management hitting ambitious ca...
HIMS Stock (Hims & Hers Health): 59% Revenue Jump to $2.35B in 2025 - Buy or Avoid? 19.04.2026 4:59
Hims & Hers has exploded from a niche telehealth startup into a social-media darling, turning awkward health conversations into a direct-to-consumer business with a recognizable brand. The company ($HIMS) now sells subscriptions, prescriptions, and a widening slate of services—from skincare and mental health to GLP-1 weight-loss offerings—while pushing into the UK and Australia. Investors face...
AXTI Stock (AXT): $21M Loss Doubles Amid China Risk – Buy or Avoid? 18.04.2026 6:27
AXT, Inc. ($AXTI) is a specialist in compound semiconductor wafers—the Indium Phosphide, Gallium Arsenide, and Germanium substrates that sit one step below the chips everyone talks about. In this episode, we unpack how AXT carved out a critical niche supplying the building blocks for 5G, high-speed data-center optics, lasers, sensors for autonomous vehicles, and satellite components; their vertica...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.